Manufacture, marketing and sale

View Life Sciences by content type:

Latest Life Sciences News

Featured Life Sciences content

Practice notes
Rome II—application and interpretationThis Practice Note is for use when determining applicable law in respect of events giving rise to damage, where...
Read More >
19th May
Q&As
Can a third party rely on ostensible/apparent authority where they know the person signing a document is an employee of a company not a director and...
Read More >
19th May
Practice notes
Brexit—exiting the EU under Article 50 [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note contains...
Read More >
Produced in partnership with Adam Cygan of University of Leicester 19th May
Practice notes
Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)CASE HUB See further,...
Read More >
19th May
Q&As
Can the board of a co-operative and community benefit society (a registered society) delegate powers to any third party, and can the registered...
Read More >
19th May
Practice notes
Rome Convention—introduction and interpretation [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.The UK is no longer...
Read More >
19th May
Precedents
Coronavirus (COVID-19): In addition to the below content on force majeure generally, see also: • Coronavirus (COVID-19)...
Read More >
19th May
Practice notes
Many companies and government bodies (such as HMRC) have been exposed to loss of confidential information and many other breaches of confidentiality...
Read More >
19th May
Practice notes
Introduction to retained EU lawThis Practice Note provides an introduction to retained EU law. It provides an overview of the key definitions and...
Read More >
Produced in partnership with Dr. Kieran Laird of Gowling WLG 19th May
Precedents
1 Counterparts—agreement 1.1 This agreement may be signed in any number of separate counterparts, each of which when...
Read More >
19th May
Practice notes
Model ADR clausesThis Practice Note considers model form alternative dispute resolution (ADR) clauses provided by a number of service providers,...
Read More >
19th May
Precedents
Option 1—contract signed on behalf of a company, where the authorised signatory is an individual Signed by [insert name of...
Read More >
19th May
Practice notes
Requirements of the company sealThis Practice Note provides practical guidance regarding the requirements of the company seal. Where a company has a...
Read More >
19th May
Practice notes
Brexit implementation period—enforcement [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note considers...
Read More >
19th May
Practice notes
SubcontractingThis Practice Note examines the following legal and practical matters in relation to entering into a subcontract or when granting...
Read More >
19th May
Practice notes
ScopeThis Practice Note explains trade mark law on parallel trade. Parallel imports, or ‘grey market’ goods, are genuine goods that are placed on the...
Read More >
Produced in partnership with Taylor Wessing LLP 19th May

Most recent Manufacture, marketing and sale content

Q&As
Could the remuneration (or career advancement) of a medical officer employed by a pharmaceutical company be tied to actual sales of drugs by that...
Read More >
31st Jul
Q&As
What action can a Member State competent authority take in the event that they discover a non-compliance during an inspection of a medical device...
Read More >
Produced in partnership with Peter Feldschreiber, 4 New Square, Lincolns’ Inn 31st Jul
Practice notes
An introduction to the regulation of medicinal productsEU and UK legal framework governing medicinal productsA complex array of requirements and...
Read More >
31st Jul
Practice notes
Brexit—implications of the Withdrawal Agreement for the life sciences sector [Archived]ARCHIVED: This Practice Note has been archived and is not...
Read More >
31st Jul
Q&As
Does a marketing authorisation holder (MAH) of a medicinal product need to collect information on individual cases of ‘off-label’ use if there is no...
Read More >
31st Jul
Practice notes
Clinical evaluation and performance evaluation of medical devices in the EUThis Practice Note describes key changes to the requisite clinical...
Read More >
Produced in partnership with Alison Dennis of Taylor Wessing LLP 31st Jul
Practice notes
Enforcement of the rules on advertising and promotion of medicinal productsIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the...
Read More >
31st Jul
Practice notes
An introduction to the regulation of medical devices—EU Directives regimeIn the EU, medical devices are tightly regulated by laws that govern their...
Read More >
Produced in partnership with Jane Summerfield of Hogan Lovells, Elisabethann Wright BL of Cooley (UK) LLP and Fabien Roy of Hogan Lovells 31st Jul
Practice notes
BiosimilarsIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into following the...
Read More >
Produced in partnership with Eleanor Denny, associate, and Claire Phipps-Jones, senior associate, of Bristows LLP 31st Jul
Practice notes
Pharmaceutical trade marks and parallel importsAt 11 pm on 31 December 2020 (IP completion day), the UK ceased to be subject to EU law. The UK’s...
Read More >
Produced in partnership with Oscar Benito of Gavi, the Vaccines Alliance 31st Jul
Q&As
How are online sales of medicinal products regulated?Any organisation based in the UK which offers medicines for sale to the public in the UK or in...
Read More >
31st Jul
Practice notes
Pharmaceutical pricing and reimbursementEuropean level rules on pricing and reimbursement of medicinal productsThe pricing and reimbursement of...
Read More >
31st Jul
Practice notes
The regulation of medical software, including mHealth appsIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit...
Read More >
31st Jul
Q&As
Are there any rules that dictate a strict separation of the medical and commercial roles in a pharmaceutical company, particularly with a view to...
Read More >
31st Jul
Practice notes
Marketing authorisations in the EU—regulatory procedures for approval of medicinal productsNo medicinal product may be placed on the market without...
Read More >
31st Jul
Practice notes
Regulation of e-cigarettesIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered into...
Read More >
Produced in partnership with Jaspreet Takhar of Baker McKenzie 31st Jul
Practice notes
UK regulation of cannabis-based medicinal productsThe cannabis plant can be used to produce a wide range of products with versatile purposes from...
Read More >
31st Jul
Practice notes
Advertising and promotion of medicinal productsIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation...
Read More >
31st Jul
Practice notes
Post-Brexit transition period—the regulation of medicinal productsThis Practice Note considers the potential impact of the end of the transition...
Read More >
31st Jul

Popular documents